Call for Abstracts
Abstract Submission is now closed — Thank You!
Download >> Preliminary Program,
Call for Abstracts and Registration Information 
Categories for Contributed Program
When submitting an abstract, you will be asked to select the one category from the list below that is nearest to your topic. The program committee will use the category you indicate to help them organize the abstracts into sessions, but may also regroup sessions around other themes that emerge from the submissions. Please feel free to submit an abstract on a topic that may be somewhat outside of this list. The committee cannot anticipate all of the topics that might be received; indeed, part of the purpose of a congress is to go beyond the usual categories and boundaries. We welcome presentations on topics that do not fit squarely in one of the listed categories, as long as they relate to some quantitative aspect of toxicological research.
| T01 | Liver Toxicology |
| T02 | Renal Toxicity |
| T03 | Carcinogenesis |
| T04 | Gene-Environment Interactions |
| T05 | Immunotoxicology |
| T06 | Hematoxicity |
| T07 | Pulmonary Toxicology |
| T08 | Genotoxicity |
| T09 | Neurotoxicology |
| T10 | Molecular Toxicology |
| T11 | Oxidative Stress/Reactive Oxygen Species |
| T12 | Toxicogenomics and Proteomics |
| T13 | Metabonomics |
| T14 | Developmental Toxicology |
| T15 | Male Reproductive Toxicology |
| T16 | Female Reproductive Toxicology |
| T17 | Toxicokinetics/Pharmacokinetics |
| T18 | Toxicology of the Cardiovascular System |
| T19 | Risk Assessment |
| T20 | Atmospheric Pollution |
| T21 | Ecotoxicology |
| T22 | Endocrine Modifying Substances |
| T23 | In vitro Models of Toxicity |
| T24 | Metals |
| T25 | Pesticides |
| T26 | Analytical Toxicology |
| T27 | Food Safety and Nutrition |
| T28 | Biotransformation |
| T29 | Toxicity of Nanomaterials |
| T30 | Exposure Assessment in Human Studies |
| T31 | New Concepts in Toxicology Education |
| T32 | Toxicology of Natural Products |
| T33 | Toxicology and Sensitive Populations |
| T34 | Epigenetic Mechanisms of Toxicity |
| T35 | Ligand Activated Transcription Factors |
| T36 | Persistent Organic Chemicals |
| T37 | Adverse Drug Reactions |
| T38 | Biomarkers of Toxicity |
| T39 | Drug Metabolizing Enzyme Polymorphisms |
| T40 | Clinical Case Reports |
| T41 | Other |
